CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 153 enrolled
Drug / intervention
Magnesium Oxide +1 moredrug
Likely dose
Magnesium Oxide 250 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03054805
NCT03054805Phase 4Completed
CompareCT.gov

The Effect of Probiotics on Constipation, and Intestinal Microflora in Children With Functional Constipation

Chang Gung Memorial Hospital·interventional·Posted Feb 16, 2017·Updated Aug 14, 2019

In Brief

A Phase 4 clinical trial evaluating Magnesium Oxide and MIYAIRI-BM for Functional Constipation. Completed, enrolled 153 participants.

Detailed Summary

To compare the differences of fecal microflora between constipated and non-constipated healthy children, and evaluate the efficacy of probiotics in reducing symptoms of constipation and the influence of intestinal microflora in children with functional constipation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFunctional Constipation
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 16, 2017
Enrollment StartSep 1, 2014
Primary CompletionDec 1, 2014
Study CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 9.4 years ago

Interventions

Magnesium Oxidedrug

Magnesium oxide 250 mg per day for children with weight \< 15 kg, 500 mg per day for weight \<15-30 kg, and 1000 mg per day for weight \> 30 kg

MIYAIRI-BMdrug

MIYAIRI-BM 1 g (1package) per day for children with weight \< 15 kg, 2g per day for weight 15-30 kg, and 3g per day for weight \> 30 kg